To further elucidate the activation status of the MAPK-ERK signaling pathway and the expression level of DUSP6 in osimertinib-sensitive and -resistant PDX tumors, we conducted WB analysis on PDX tumors and primary tumor cells isolated from PDX tumors. The gene discussed is DUSP6; the disease is neoplasm.